Karen Knudsen: We must address gaps in generic drug shortages!
shared a post on LinkedIn:
“Concerning upward trend – lack of access to life saving generic drugs. We have repeatedly seen this through the lens of chemotherapy drugs shortages, and called for action. We must address gaps in generic drug shortages!”
Further information.
Source:
Karen E. Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health.
She also served as president for the Association of American Cancer Institutes (AACI) and on the board of directors of the American Association for Cancer Research (AACR). She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.